Stay updated on Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.

Latest updates to the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange Detected- Revision and footer policy updates: added Revision: v3.3.3, removed HHS Vulnerability Disclosure and Revision: v3.3.2; no changes to the study content or page functionality.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision tag updated to v3.3.2; the previous v3.2.0 tag was removed.SummaryDifference0.0%

- Check48 days agoChange DetectedRemoved the government funding/operating status notice that previously warned users information may not be up to date and that NIH operations could be affected.SummaryDifference0.3%

- Check69 days agoChange DetectedMinor visual/layout adjustments and a more recent last-updated timestamp, with core study details unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a full Neoadjuvant/Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy study (SAKK 06/17), detailing objective, design, criteria, endpoints, and locations; no deletions were reported.SummaryDifference100%

- Check91 days agoChange DetectedUpdated core page content to reflect a version bump to v3.2.0 and a government-operating-status notice; removed the previous v3.1.0 version tag.SummaryDifference3%

Stay in the know with updates to Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.